Metchnikoff and the centenary of probiotics: An update of their use in gastroenteric pathology during the age of development;Metchnikoff e il centenario dei probiotici: Update del loro impiego nella patologia gastroenterica in età evolutiva

Minerva Pediatrica

Volumn 60, Issue 6, 2008, Pages 1417-1435

  Caramia, G ^a  

^a Neonatology and Pediatric Department   (Italy)

Author keywords

Diarrhea; Gastroenteritis; Lactobacillus; Probiotics

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; CLINDAMYCIN; METRONIDAZOLE; PENICILLIN DERIVATIVE; PROBIOTIC AGENT; VANCOMYCIN;

ACUTE GASTROENTERITIS; ANTIBIOTIC THERAPY; BACILLUS; BACILLUS CLAUSII; BACTERIAL COLONIZATION; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM BIFIDUM; BREAST FEEDING; CLOSTRIDIUM DIFFICILE; DIARRHEA; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GASTROENTERITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTIOUS DIARRHEA; INFLAMMATORY DISEASE; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS DELBRUECKII; LACTOBACILLUS RHAMNOSUS; NECROTIZING ENTEROCOLITIS; ORAL REHYDRATION THERAPY; PATHOLOGY; RECURRENT INFECTION; REVIEW; RISK REDUCTION; SACCHAROMYCES BOULARDII; SALMONELLA; STREPTOCOCCUS; STREPTOCOCCUS THERMOPHILUS; TREATMENT DURATION;

ACUTE DISEASE; CHILD, PRESCHOOL; DIARRHEA; DIARRHEA, INFANTILE; ENTEROCOLITIS, NECROTIZING; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FRANCE; GASTROENTERITIS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; INFANT; INFANT, NEWBORN; LACTOBACILLUS; META-ANALYSIS AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RUSSIA (PRE-1917);

EID: 57749176409     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Giovannini M, Agostoni C, Riva E, Salvini F, Ruscitto A, Zuccotti GV et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Felicita Study Group. Pediatr Res 2007;62:215-20.
2. Zuccotti GV, Meneghin F, Raimondi C, et al. Probiotics in clinical practice: an overview. J Int Med Res 2008;36(Suppl 1):1A-53A.
3. Guslandi M. A natural approach to treatment of inflammatory bowel disease. Br J Clin Pharmacol 2008;65:468-9.
4. Metchnikoff E. The Prolongation of life. Optimistic studies. London; William Heinemann; 1907. Oxford: Putman and sons; 1908. p. 1-38.
5. Damaskos D, Kolios G. Probiotics and prebiotics in inflammatory bowel disease: microflora on the scope. Br J Clin Pharmacol 2008;65:453-67.
6. Goldin BR, Gorbach SL. Clinical indications for probiotics: an overview. Clin Infect Dis 2008;46(Suppl 2):S96-100.
7. Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double-blind, placebo-controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhea. DICP 1990;24:382-4.
8. Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ 2006;175:377-83.
9. Ansaldi F, Lai P, Valle L, Riente R, Durando P, Sticchi L et al. Burden of rotavirus-associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance. Clin Infect Dis 2008;46:51-5.
10. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-9.
11. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000;30:54-60.
12. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002;109:678-84.
13. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotics use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002; 47:2635-34.
14. Allen S, Okoko B, Martinez E, Gregorio G. Probiotics for treating infectious diarrhoea Cochrane Review. In: The Cochrane Library, Issue 4, 2004.
15. Szymafski H, Pejcz J, Jawief M, Chmielarczyk A, Strus M, Heczko PB. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains - a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006;23:247-53.
16. Szymanski H, Chmielarczyk A, Strus M, Pejcz J, et al. Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children. Dig Liver Dis 2006;38(Suppl 2):S274-6.
17. Szajewska H, Setty M, Mrukowicz J, Guandalini S. Probiotics in gastrointestinal diseases in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr 2006;42:454-75.
18. Szajewska H, Skórka A, Ruszczyfski M, Gieruszczak-BiaΠek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment Pharmacol Ther 2007;25:871-81.
19. Szajewska H. Probiotics and prebiotics in pediatrics: where are we now? Turk J Pediatr 2007;49:231-44.
20. Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 2007;335:340.
21. Salvatore S, Hauser B, Devreker T, Vieira MC, Luini C, Arrigo S et al. Probiotics and zinc in acute infectious gastroenteritis in children: are they effective? Nutrition 2007;23:498-506.
22. Lemberg DA, Ooi CY, Day AS. Probiotics in paediatric gastrointestinal diseases. J Paediatr Child Health 2007;43:331-6.
23. Pham M, Lemberg DA, Day AS. Probiotics: sorting the evidence from the myths. Med J Aust 2008;188:304-8.
24. Khaled A, Ahmad F, Brogan T, et al. Prescription medicine use by one million Canadian children. Paediatr Child Health 2003;8(Suppl A):43A-5A
25. Goossens H, Ferech M, Coenen S, Stephens P. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. European Surveillance of Antimicrobial Consumption Project Group. Clin Infect Dis 2007;44:1091-5.
26. Wiström J, Norrby SR, Myhre EB, Eriksson S, Granström G, Lagergren L et al. Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001;47:43-50.
27. La Rosa M, Bottaro G, Gulino N, Gambuzza F, Di Forti F, Inì G et al. Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children: a multicentric double-blind vs placebo study. Minerva Pediatr 2003;55:447-52.
28. Torek D, Bernet JP, Marx J, Kempf H, Giard P, Walbaum O et al. Incidence and risk factors for of oral antibiotic associated diarrhea in an outpatient pediatric population. J Pediatr Gastroenterol Nutr 2003;37:22-6.
29. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig Dis 1998;16:292-307.
30. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic-associated diarrhea: meta-analysis. BMJ 2002;324:1361-7.
31. Johnston BC, Supina AL, Ospina M, Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2007;2:CD004827.
32. Szajewska H, Ruszczyfski M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J Pediatr 2006;149:367-72.
33. Giesemann T, Egerer M, Jank T, Aktories K. Processing of Clostridium difficile toxins. J Med Microbiol 2008;57:690-6.
34. Barbut F, Gariazzo B, Bonné L, Lalande V, Burghoffer B, Luiuz R et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 2007;28:131-9.
35. Elliott B, Chang BJ, Golledge CL, Riley TV. Clostridium difficile-associated diarrhoea. Intern Med J 2007;37:561-8.
36. Du T, Alfa MJ. Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A. Can J Infect Dis 2004;15:83-8.
37. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000;31:1012-7.
38. Surawicz CM. Treatment of recurrent Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2004;1:32-8.
39. Katz JA. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea. J Clin Gastroenterol 2006;40:249-55.
40. Langley JM, LeBlanc JC, Hanakowski M, Goloubeva O. The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children. Infect Control Hosp Epidemiol 2002;23:660-4.
41. O uz F, Uysal G, Dafldemir S, Oskovi H, Vidinlisan S. The role of Clostridium difficile in childhood nosocomial diarrhea. Scand J Infect Dis 2001;33:731-3.
42. Morinville V, McDonald J. Clostridium difficile-associated diarrhea in 200 Canadian children. Can J Gastroenterol 2005;19:497-501.
43. Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol 2007;28:1233-5.
44. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006;101:812-22.
45. Segarra-Newnham M. Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii. Ann Pharmacother 2007;41:1212-21.
46. Pelleschi ME. Clostridium difficile-Associated Disease: Diagnosis, Prevention, Treatment, and Nursing Care. Crit Care Nurse 2008;28:27-35.
47. Martin CR, Walker WA. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008;32:127-37.
48. Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 2008;32:70-82.
49. Manzoni P, Mostert M, Leonessa ML, Priolo C, Farina D, Monetti C et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006;15:1735-42.
50. Hunter CJ, Upperman JS, Ford HR, Camerini V. Understanding the susceptibility of the premature infant to necrotizing enterocolitis (NEC). Pediatr Res 2008;63:117-23.
51. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. Biol Neonate 2002;82:103-8.
52. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005;147:192-6.
53. Barclay AR, Stenson B, Simpson JH, Weaver LT, Wilson DC. Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 2007;45:569-76.
54. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007;369:1614-20.
55. Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008;CD005496.
56. Elmer GM, McFarland LV. Properties of evidence-based probiotics for human health. In: Goklepe I, Juneja V, editors. Probiotics in food safety and human health. New York: Marcel Dekker Inc.; 2005. p. 109-37.
57. Hoffman FA. Business considerations in the development of probiotics. Clin Infect Dis 2008;46 Suppl 2: S141-3.